NFKB1 and Arterial thrombosis: ALR-S inhibited platelet adhesion to VECs and rebalanced thrombotic/antithrombotic factor expression and secretion by inhibiting the oxidative stress and ERK/NF-κB pathway in VECs, which may lead to the VEC protection and the alleviation of arterial thrombosis.